Fuertes, Mitch Gian .

HRN: 22-33-93  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2023
CEFUROXIME 750MG (VIAL)
11/06/2023
11/12/2023
IVT
260mg
Q8hrs
Age With Mod Dhn; PCAP B
Waiting Final Action 
11/06/2023
MUPIROCIN 2%, 15G (TUBE)
11/06/2023
11/12/2023
TOPICAL
Apply On Affected Area
TID
Skin Lesion
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: